Regenerative Medical Technology Group Inc. (RMTG) stock
RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
$0.04−0.00 (-5.76%)
Close on Oct 19, 2026Market cap $497.25KP/E –Yield –
Regenerative Medical Technology free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Regenerative Medical Technology's free cash flow for the twelve months ending Jun 30, 2026 was -$582.33K. For fiscal 2025 it was -$1.31M, down 306.1% from the year before. The highest annual figure on record is $635.28K in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.31M | -306.1% |
| FY2024 | Dec 31, 2024 | $635.28K | – |
| FY2023 | Dec 31, 2023 | -$804.80K | – |
| FY2022 | Dec 31, 2022 | -$1.31M | – |
| FY2020 | Dec 31, 2020 | -$422.75K | – |
| FY2019 | Dec 31, 2019 | -$462.33K | – |
| FY2018 | Dec 31, 2018 | -$248.64K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $288.48K | -12.4% |
| Q1 FY2026 | Mar 31, 2026 | -$213.27K | -197.2% |
| Q4 FY2025 | Dec 31, 2025 | -$228.98K | -706.7% |
| Q3 FY2025 | Sep 30, 2025 | -$428.56K | -978.0% |
| Q4 FY2024 | Dec 31, 2024 | $329.39K | – |
| Q3 FY2024 | Sep 30, 2024 | $219.33K | – |
| Q2 FY2024 | Jun 30, 2024 | $37.74K | – |
| Q1 FY2024 | Mar 31, 2024 | $48.81K | +3686.8% |
| Q4 FY2023 | Dec 31, 2023 | -$313.40K | – |
| Q3 FY2023 | Sep 30, 2023 | -$81.25K | – |
| Q2 FY2023 | Jun 30, 2023 | -$411.43K | – |
| Q1 FY2023 | Mar 31, 2023 | $1.29K | – |
| Q4 FY2022 | Dec 31, 2022 | -$117.96K | – |
| Q3 FY2022 | Sep 30, 2022 | -$153.44K | – |
| Q1 FY2021 | Mar 31, 2021 | -$254.86K | – |
| Q4 FY2020 | Dec 31, 2020 | -$96.94K | – |
| Q3 FY2020 | Sep 30, 2020 | -$92.10K | – |
| Q2 FY2020 | Jun 30, 2020 | -$69.03K | – |
| Q1 FY2020 | Mar 31, 2020 | -$164.68K | – |
| Q4 FY2019 | Dec 31, 2019 | -$48.45K | – |
| Q3 FY2019 | Sep 30, 2019 | -$134.68K | – |
| Q2 FY2019 | Jun 30, 2019 | -$86.57K | – |
| Q1 FY2019 | Mar 31, 2019 | -$192.63K | – |
| Q4 FY2018 | Dec 31, 2018 | -$73.87K | – |
See a number that looks wrong?